In-Vitro Colorectal Cancer Screening Tests Market Size by Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screening Tests [Methylated Gene Testing, Panel DNA Tests]), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Feb 2019  |  Report ID: GMI451  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 140   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. In-Vitro colorectal cancer screening tests industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Test type trends

2.1.3. Regional trends

Chapter 3. In-Vitro Colorectal Cancer Screening Tests Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Improvements in colorectal cancer screening through non-invasive methods

3.3.1.2. Advancements in the field of diagnosis

3.3.1.3. Rising prevalence of colorectal cancer

3.3.1.4. Cost-efficient and High-speed DNA sequencing

3.3.2. Industry pitfalls & challenges

3.3.2.1. Lack of uniform cancer screening guidelines in Asia Pacific

3.3.2.2. Inadequate reimbursement coverage

3.3.2.3. Shortage of trained staff in developing regions

3.4. Regulatory landscape

3.4.1. U.S.

3.4.2. Europe

3.4.3. China

3.5. Technology landscape

3.6. Growth potential analysis

3.6.1. By test type

3.7. Porter’s analysis

3.8. Competitive landscape, 2017

3.8.1. Strategy dashboard

3.9. PESTEL analysis

Chapter 4. In-Vitro Colorectal Cancer Screening Tests Market, By Test Type

4.1. Key segment trends

4.2. Fecal occult blood test (FOBT)

4.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.2. Guaiac FOB stool test

4.2.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.3. Immuno-FOB agglutination test

4.2.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.4. Lateral flow immuno-FOB test

4.2.4.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.2.5. Immuno-FOB ELISA test

4.2.5.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.3. Biomarker test

4.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.3.2. Tumor M2-PK stool test

4.3.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.3.3. Transferrin assays

4.3.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.4. CRC DNA screening test

4.4.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.4.2. Methylated gene test

4.4.2.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

4.4.3. Panel DNA test

4.4.3.1. Market estimates and forecast, by region, 2014 - 2025 (USD Million)

Chapter 5. In-Vitro Colorectal Cancer Screening Tests Market, By Region

5.1. Key segment trends

5.2. North America

5.2.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.2.2. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.2.2.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.2.2.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.2.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.2.3. U.S.

5.2.3.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.2.3.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.2.3.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.2.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.2.4. Canada

5.2.4.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.2.4.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.2.4.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.2.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.3. Europe

5.3.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.3.2. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.3.2.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.3.2.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.3.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.3.3. Germany

5.3.3.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.3.3.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.3.3.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.3.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.3.4. UK

5.3.4.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.3.4.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.3.4.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.3.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.3.5. France

5.3.5.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.3.5.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.3.5.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.3.5.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.3.6. Italy

5.3.6.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.3.6.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.3.6.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.3.6.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.3.7. Spain

5.3.7.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.3.7.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.3.7.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.3.7.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.4. Asia Pacific

5.4.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.4.2. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.4.2.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.4.2.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.4.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.4.3. Japan

5.4.3.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.4.3.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.4.3.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.4.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.4.4. China

5.4.4.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.4.4.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.4.4.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.4.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.4.5. India

5.4.5.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.4.5.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.4.5.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.4.5.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.4.6. Australia

5.4.6.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.4.6.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.4.6.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.4.6.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.5. Latin America

5.5.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.5.2. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.5.2.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.5.2.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.5.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.5.3. Brazil

5.5.3.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.5.3.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.5.3.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.5.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.5.4. Mexico

5.5.4.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.5.4.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.5.4.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.5.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.6. MEA

5.6.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.6.2. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.6.2.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.6.2.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.6.2.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.6.3. South Africa

5.6.3.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.6.3.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.6.3.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.6.3.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

5.6.4. Saudi Arabia

5.6.4.1. Market estimates and forecast, by test type, 2014 – 2025 (USD Million)

5.6.4.1.1. Market estimates and forecast, by FOBT, 2014 – 2025 (USD Million)

5.6.4.1.2. Market estimates and forecast, by biomarker test, 2014 – 2025 (USD Million)

5.6.4.1.3. Market estimates and forecast, by CRC DNA screening test, 2014 – 2025 (USD Million)

Chapter 6. Company Profiles

6.1. Abbott Molecular Inc.

6.1.1. Business overview

6.1.2. Financial data

6.1.3. Product landscape

6.1.4. Strategic outlook

6.1.5. SWOT analysis

6.2. Alere Inc.

6.2.1. Business overview

6.2.2. Financial data

6.2.3. Product landscape

6.2.4. Strategic outlook

6.2.5. SWOT analysis

6.3. Beckman Coulter Inc.

6.3.1. Business overview

6.3.2. Financial data

6.3.3. Product landscape

6.3.4. Strategic outlook

6.3.5. SWOT analysis

6.4. Eiken Chemical

6.4.1. Business overview

6.4.2. Financial data

6.4.3. Product landscape

6.4.4. Strategic outlook

6.4.5. SWOT analysis

6.5. Epigenomics AG Corporation

6.5.1. Business overview

6.5.2. Financial data

6.5.3. Product landscape

6.5.4. Strategic outlook

6.5.5. SWOT analysis

6.6. Sysmex Corporation

6.6.1. Business overview

6.6.2. Financial data

6.6.3. Product landscape

6.6.4. Strategic outlook

6.6.5. SWOT analysis

6.7. Siemens Healthcare

6.7.1. Business overview

6.7.2. Financial data

6.7.3. Product landscape

6.7.4. Strategic outlook

6.7.5. SWOT analysis

6.8. Quest Diagnostics Incorporated

6.8.1. Business overview

6.8.2. Financial data

6.8.3. Product landscape

6.8.4. Strategic outlook

6.8.5. SWOT analysis

6.9. CompanianDx

6.9.1. Business overview

6.9.2. Financial data

6.9.3. Product landscape

6.9.4. Strategic outlook

6.9.5. SWOT analysis

6.10. OncoCyte Corporation-Biotime

6.10.1. Business overview

6.10.2. Financial data

6.10.3. Product landscape

6.10.4. Strategic outlook

6.10.5. SWOT analysis

6.11. Merck Millipore

6.11.1. Business overview

6.11.2. Financial data

6.11.3. Product landscape

6.11.4. Strategic outlook

6.11.5. SWOT analysis

6.12. GeneNews Ltd.

6.12.1. Business overview

6.12.2. Financial data

6.12.3. Product landscape

6.12.4. Strategic outlook

6.12.5. SWOT analysis

6.13. BioMarCare Technologies Ltd

6.13.1. Business overview

6.13.2. Financial data

6.13.3. Product landscape

6.13.4. Strategic outlook

6.13.5. SWOT analysis

6.14. Immunostics Inc.

6.14.1. Business overview

6.14.2. Financial data

6.14.3. Product landscape

6.14.4. Strategic outlook

6.14.5. SWOT analysis

6.15. ExiQon

6.15.1. Business overview

6.15.2. Financial data

6.15.3. Product landscape

6.15.4. Strategic outlook

6.15.5. SWOT analysis

6.16. Kyowa Medex Co. Ltd.

6.16.1. Business overview

6.16.2. Financial data

6.16.3. Product landscape

6.16.4. Strategic outlook

6.16.5. SWOT analysis

6.17. Mode Diagnostics

6.17.1. Business overview

6.17.2. Financial data

6.17.3. Product landscape

6.17.4. Strategic outlook

6.17.5. SWOT analysis

6.18. Randox Laboratories Ltd

6.18.1. Business overview

6.18.2. Financial data

6.18.3. Product landscape

6.18.4. Strategic outlook

6.18.5. SWOT analysis

6.19. R-Biopharm Incorporation

6.19.1. Business overview

6.19.2. Financial data

6.19.3. Product landscape

6.19.4. Strategic outlook

6.19.5. SWOT analysis
 

Data Tables

TABLE 1.    In-vitro colorectal cancer screening test industry 360º synopsis, 2014 – 2025

TABLE 2.    Global In-Vitro colorectal cancer screening tests market, 2014 – 2018 (USD Million)

TABLE 3.    Global In-Vitro colorectal cancer screening tests market, 2019 – 2025 (USD Million)

TABLE 4.    Global In-Vitro colorectal cancer screening tests market, by test type, 2014 - 2025 (USD Million)

TABLE 5.    Global In-Vitro colorectal cancer screening tests market, by region, 2014 – 2025 (USD Million)

TABLE 6.    Industry impact forces

TABLE 7.    Guideline for various patient group 

TABLE 8.    Fecal occult blood test market estimates and forecast, by region, 2014 – 2025 (USD Million)

TABLE 9.    Guaiac FOB stool test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 10.    Immuno-FOB agglutination test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 11.    Lateral flow immuno-FOB test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 12.    Immuno-FOB ELISA test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 13.    Biomarker test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 14.    Tumor M2-PK stool test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 15.    Transferrin assays market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 16.    CRC DNA screening test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 17.    Methylated gene test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 18.    Panel DNA test market estimates and forecast, by region, 2014 - 2025 (USD Million)

TABLE 19.    North America In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)

TABLE 20.    North America In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 21.    North America In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 22.    North America In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 23.    North America In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 24.    U.S. In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 25.    U.S.  In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 26.    U.S. In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 27.    U.S. In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 28.    Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 29.    Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 30.    Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 31.    Canada In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 32.    Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)

TABLE 33.    Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 34.    Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 35.    Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 36.    Europe In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 37.    Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 38.    Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 39.    Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 40.    Germany In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 41.    UK In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 42.    UK In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 43.    UK In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 44.    UK In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 45.    France In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 46.    France In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 47.    France In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 48.    France In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 49.    Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 50.    Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 51.    Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 52.    Italy In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 53.    Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 54.    Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 55.    Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 56.    Spain In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 57.    Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)

TABLE 58.    Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 59.    Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 60.    Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 61.    Asia Pacific In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 62.    Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 63.    Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 64.    Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 65.    Japan In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 66.    Estimated New Cancer Cases and Deaths (Thousands) by Age Groups, 2015

TABLE 67.    China In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 68.    China In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 69.    China In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 70.    China In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 71.    India In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 72.    India In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 73.    India In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 74.    India In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 75.    Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 76.    Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 77.    Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 78.    Australia In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 79.    Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)

TABLE 80.    Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 81.    Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 82.    Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 83.    Latin America In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 84.    Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 85.    Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 86.    Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 87.    Brazil In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 88.    Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 89.    Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 90.    Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 91.    Mexico In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 92.    MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by country, 2014 - 2025 (USD Million)

TABLE 93.    MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 94.    MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 95.    MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 96.    MEA In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 97.    South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 98.    South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 99.    South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 100.    South Africa In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)

TABLE 101.    Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by test type, 2014 - 2025 (USD Million)

TABLE 102.    Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by FOBT, 2014 - 2025 (USD Million)

TABLE 103.    Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by biomarker tests, 2014 - 2025 (USD Million)

TABLE 104.    Saudi Arabia In-Vitro colorectal cancer screening tests market estimates and forecast, by CRC DNA screening test, 2014 - 2025 (USD Million)
 

Charts & Figures

FIG 1.    Industry segmentation

FIG 2.    Global in-vitro colorectal cancer screening tests market, 2014- 2025 (USD Million)

FIG 3.    Growth potential analysis, by test type

FIG 4.    Porter’s analysis

FIG 5.    Strategy dashboard

FIG 6.    PESTEL analysis
 

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Feb 2019
  • Pages: 140
  • Tables: 104
  • Charts / Figures: 6
  • Companies covered: 19
  • Countries covered: 15

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X